Stephen L. Rawlings

Array ( [id] => 14821043 [patent_doc_number] => 10407513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-10 [patent_title] => Biological products [patent_app_type] => utility [patent_app_number] => 13/121055 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 30 [patent_no_of_words] => 21219 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6379340 [patent_doc_number] => 20100081796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'BISPECIFIC ANTI-EGFR/ANTI-IGF-1R ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/565786 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 35127 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081796.pdf [firstpage_image] =>[orig_patent_app_number] => 12565786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289728 [patent_doc_number] => 20100158871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Sickled erythrocytes with antitumor molecules induce tumoricidal effects' [patent_app_type] => utility [patent_app_number] => 12/586532 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 55509 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158871.pdf [firstpage_image] =>[orig_patent_app_number] => 12586532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6567898 [patent_doc_number] => 20100017898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'THERAPEUTIC APPLICATIONS OF NONCOVALENT DIMERIZING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/562765 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6094 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20100017898.pdf [firstpage_image] =>[orig_patent_app_number] => 12562765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576897 [patent_doc_number] => 20100047254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'High Affinity Human Antibodies to Human IL-4 Receptor' [patent_app_type] => utility [patent_app_number] => 12/556605 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9513 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047254.pdf [firstpage_image] =>[orig_patent_app_number] => 12556605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691290 [patent_doc_number] => 08821880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Methods and agents for the diagnosis and treatment of hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 13/126734 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 100 [patent_figures_cnt] => 186 [patent_no_of_words] => 31546 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22777 [patent_doc_number] => 07794717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'High affinity human antibodies to human IL-4 receptor' [patent_app_type] => utility [patent_app_number] => 12/554029 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10952 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794717.pdf [firstpage_image] =>[orig_patent_app_number] => 12554029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594988 [patent_doc_number] => 20100062443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Methods for the Diagnosis and Treatment of Lung Cancer' [patent_app_type] => utility [patent_app_number] => 12/545028 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14323 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062443.pdf [firstpage_image] =>[orig_patent_app_number] => 12545028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6482018 [patent_doc_number] => 20100008853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'ANTI GANGLIOSIDE GD3 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/541958 [patent_app_country] => US [patent_app_date] => 2009-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12002 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008853.pdf [firstpage_image] =>[orig_patent_app_number] => 12541958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11463894 [patent_doc_number] => 09580513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'VHZ for diagnosis and treatment of cancers' [patent_app_type] => utility [patent_app_number] => 13/058055 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 32 [patent_no_of_words] => 53101 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13058055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7978135 [patent_doc_number] => 08071815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'CTIP2 expression in squamous cell carcinoma' [patent_app_type] => utility [patent_app_number] => 12/505437 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 27639 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071815.pdf [firstpage_image] =>[orig_patent_app_number] => 12505437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142208 [patent_doc_number] => 20110129478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/002636 [patent_app_country] => US [patent_app_date] => 2009-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16409 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129478.pdf [firstpage_image] =>[orig_patent_app_number] => 13002636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466290 [patent_doc_number] => 20100040537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Prostaglandin E2 Binding Proteins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/499646 [patent_app_country] => US [patent_app_date] => 2009-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 55776 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040537.pdf [firstpage_image] =>[orig_patent_app_number] => 12499646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969092 [patent_doc_number] => 20110150903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'FGF-R4 RECEPTOR-SPECIFIC ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/002845 [patent_app_country] => US [patent_app_date] => 2009-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19653 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150903.pdf [firstpage_image] =>[orig_patent_app_number] => 13002845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574450 [patent_doc_number] => 20100129356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT' [patent_app_type] => utility [patent_app_number] => 12/497405 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 43314 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129356.pdf [firstpage_image] =>[orig_patent_app_number] => 12497405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7652063 [patent_doc_number] => 20110301332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'ANTI-PAMP THERAPEUTIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/001744 [patent_app_country] => US [patent_app_date] => 2009-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27138 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301332.pdf [firstpage_image] =>[orig_patent_app_number] => 13001744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676918 [patent_doc_number] => 08815828 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Therapeutic combinations for use in neoplasia' [patent_app_type] => utility [patent_app_number] => 12/997199 [patent_app_country] => US [patent_app_date] => 2009-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21262 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12997199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397316 [patent_doc_number] => 20090317379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'AUTOPHILIC ANTIBODIES AND METHOD OF MAKING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/481248 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12079 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317379.pdf [firstpage_image] =>[orig_patent_app_number] => 12481248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142132 [patent_doc_number] => 20110129457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'VARIANT HHIP1 PROTEIN AND METHODS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/995442 [patent_app_country] => US [patent_app_date] => 2009-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 69982 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129457.pdf [firstpage_image] =>[orig_patent_app_number] => 12995442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533527 [patent_doc_number] => 20090233315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'MAGE-C2 antigenic peptides and uses therefor' [patent_app_type] => utility [patent_app_number] => 12/387884 [patent_app_country] => US [patent_app_date] => 2009-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19683 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233315.pdf [firstpage_image] =>[orig_patent_app_number] => 12387884 [rel_patent_id] =>[rel_patent_doc_number] =>)